2020, Number 2
<< Back Next >>
Revista Cubana de Anestesiología y Reanimación 2020; 19 (2)
Anesthesia in juvenile angiofibroma: an challenge for the anesthesiologist
Cordero EI, Pérez CA
Language: Spanish
References: 26
Page: 1-22
PDF size: 528.64 Kb.
ABSTRACT
Introduction:
Anesthesia for juvenile angiofibroma is one of the most complex interventions within otolaryngology, since incoercible bleeding causes acute hypovolemia, which occurs in a short period and leads to hypovolemic shock and death if not treated properly.
Objective:
To carry out an update about the perioperative period of anesthesia in juvenile angiofibroma.
Development:
Blood losses must be minimized at all costs. The best association was induced hypotension, hypovolemic hemodilution, and autologous blood predeposit, with angiography and selective arterial embolization of the tumor.
Conclusions:
Surgical removal of juvenile angiofibroma is a high-risk intervention. The work team is an essential element. The association of induced hypotension, hypovolemic hemodilution, and autologous blood predeposit are the fundamental pillars for the best evolution of these patients.
REFERENCES
Vélez H. Fundamentos de medicina interna. Hematología. 5 ed, Medellín, CIB. 1998. pp. 27-9.
Avall A, Hylliner M, Bengston P, Carlson L, Bengston A. Postoperative inflammatory response after autologous and allogenic blood transfusion. Anesthesiology. 1997;87:511-5.
Maness P, Rusell S, Altonji P, Allimendinger P. Bloodless medicine and surgery. AORN J. 1998;67:144-52.
García García E, Rodríguez Casas E, Raola Sánchez ME, Sánchez Rodríguez K. Consumo de transfusiones sanguíneas en operaciones electivas realizadas por el servicio de cirugía general. Rev Cubana Antes Rean 2007[acceso: 05/12/2018]. Dsiponible en: http://bvs.sld.cu/revistas/scar/scar06_03_07/scar06307.htm
Coplay LA, Richards BS, Safavi FZ, Newton PO. Hemodilution as a method to reduce transfusion requirements in adolescent's spine fusion surgery spine. Spine. 1999;24(3):219-24.
Nagai M. History of autologous blood transfusion in neurosurgical operacition. No Shinkei Geka. 1998;26(12):1117-22.
McFarland JG. Perioperative blood transfusion, indications, and options. Chest. 1999; 115:113-20.
Dalton J. Bloodless surgery growing as patients demand alternatives. Health Industry Today. 1998;61:111.
Messmer K, Sunder-Plassman L, Jesch F. Oxygen supply to the tissues during limited normovolemic hemodilution. Res Exp Med. 1973;159:152-66.
Trouwborst A, Van Bommet J, Ince C, Henny PC. Monitoring normovolaemic haemodilution. Br J Anaesth. 1998;81:73-81.
Beloto de Souza MA, Klamt JG, Garcia LV. Effects of acute normovolemic hemodilution on blood coagulation: comparison between tests of an in vivo and an in vitro model. Rev Bras Anestesiol. 2010[acceso: 15/09/2018];60(4). Disponible en: http://dx.doi.org/10.1590/S0034-70942010000400003
Vinent Oduardo M, Carulla Diez BM, Lachaise Moreno Y, Carulla Ballester A, Muguercia Sarracé K. Hemodilución normovolémica aguda en pacientes expuestos a cirugía de revascularización coronaria. Medisan. 2015[acceso: 15/09/2018];19(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015001200001
Stoelting A. Anesthesia and Co-Existing Disease. California: Interamericana Ed; 2000. pp. 205-7.
Sujeet R, Satyajeet V, Pramod KY, Jawed A, Harikesh KY. Utility of Acute Normovolemic Hemodilution in Major Surgeries in Rural Area: A Prospective Comparative Study from North India. Anesth Essays Res. 2017;11(4):909-12.
Shidhaye RV, Divekar DS, Lakhkar V, Lakhkar V, Shidhaye R. Comparative study of acute normovolaemic haemodilution and acute hypervolaemic haemodilution in major surgical procedures. Anaesth Pain Intensive Care. 2010;14:21-6.
Naqash IA, Draboo MA, Lone AQ, Nengroo SH, Kirmani A, Bhat AR. Evaluation of acute normovolemic hemodilution and autotransfusion in neurosurgical patients undergoing excision of intracranial meningioma. J Anaesthesiol Clin Pharmacol. 2011;27:54-8.
Winter V, Gille J, Richter A, Sablotzki A, Wiedemann B. Preoperative hypervolemic hemodilution with 6 % hydroxyethyl starch 130/0,4 (HES 130/0.4) solution as a way of reducing needs for donor blood transfusion. Anaeteziol Reanimatol. 2006;2:43-7.
Van Aken J. Deliberate Hypotension. Elsiever Ed. Mexico. 2000. pp. 22-34.
Rogers M. Deliberate Hypotension. In: Principles and Practice of Anesthesiology. St. Louis, Missouri: Mosby-Year Book;1993. pp. 2422-26.
Levi M, Croheccke ME, Jonge E, Prins MJ. Pharmacological strategies to decrease excessive blood loss in cardiac surgery. Meta-analysis of clinically relevant endpoints. Lancet. 1999;354(9194):1940-7.
Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115(22):2801-13.
de JH Shuhaiber. Does perioperative use of aprotinin reduce the rejection rate in heart. Europ J Cardio-thoracic Surgery. 2008;33:849-55.
Smith PP, Muhlbaier L. Aprotinin safe and effective only whit the full-dose regimen. J Soc Thorax Surg. 1998;62:1575-7.
Smith PK, Datta SK, Muhlbaier LH, Samsa G, Nadel A, Lipscomb J. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. The Annals Thoracic Surgery. 2004;77(2): 635-42.
Flores AWE, Venero CP, De la Campa JD, Cordero EI, Hierro GE, Torres CBL, et al. Tratamiento quirúrgico de angiofibroma juvenil mediante proceso secuencial de atención. Resultados en 81 pacientes. Ludovico Pediátrica. 2007;9(2):39-48.
García García E. Pautas transfusionales en el paciente quirúrgico. Rev cubana anestesiol reanim. 2013[acceso: 30/10/2018];12(3). Disponible en: http://scielo.sld.cu/scielo.php? script=sci_arttext&pid=S1726-67182013000300007